<DOC>
	<DOC>NCT00541996</DOC>
	<brief_summary>The purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.</brief_summary>
	<brief_title>Study Comparing Bioavailability of Oral Formulations of Vabicaserin</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Healthy men aged 1850 years. Any significant disease state. History of drug or alcohol abuse within 1 year. Abnormal liver function tests.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>